Sanofi’s profit growth beats market expectations thanks to early start of vaccine sales

French drugmaker Sanofi on Friday posted stronger third-quarter profit growth than analysts expected, helped by an earlier-than-expected start to the vaccination season.

Compartir esta publicacion: